Search results
Results from the WOW.Com Content Network
Emerging Infectious Diseases (EID) is an open-access, peer-reviewed journal published by the Centers for Disease Control and Prevention (CDC). [1] EID is a public domain [ 2 ] journal and covers global instances of new and reemerging infectious diseases , putting greater emphasis on disease emergence, prevention , control, and elimination.
An emerging infectious disease (EID) is an infectious disease whose incidence has increased recently (in the past 20 years), and could increase in the near future. [ 2 ] [ 3 ] The minority that are capable of developing efficient transmission between humans can become major public and global concerns as potential causes of epidemics or ...
ISARIC was founded in 2011. [4] In 2012, ISARIC joined with the World Health Organization to launch the Clinical Characterisation Protocol (CCP) program. [5] Its founders cited the 2002–2004 SARS outbreak, 2009 swine flu outbreak and later 2012 MERS outbreak as inciting incidents for the creation of an open source platform for sharing clinical research on emerging infectious diseases.
The IATF-EID convened in January 2020 to address the growing viral outbreak in Wuhan, China. [5] They made a resolution to manage the spreading of the new virus, [5] which was known at the time as 2019 novel coronavirus (2019-nCoV) and eventually renamed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19. [6]
The Infectious Diseases Fellowship Program is open to physicians who have completed three years of an internal medicine residency program in the United States or Canada. [20] Fellows are eligible to sit for the ABIM Infectious Disease certification examination after two years. Christa Zerbe is currently the program director for the Infectious ...
Scientific Advisory Group for Origins of Novel Pathogens (or SAGO) [1] [2] [3] is a permanent advisory body of the World Health Organization, formed in July 2021, with a broad objective to examine emerging infectious diseases, including COVID-19.
The lab is part of a national network of secure facilities that study infectious diseases, whether naturally occurring or introduced through bioterrorism. NEIDL is one of only 13 operational or planned biosafety level 4 (BSL-4) laboratories in the United States. NEIDL's current director is Nancy Sullivan, ScD.
The Society sponsors the HIV Medicine Association (HIVMA), an organization of HIV researchers and specialists, and funds research fellowships for junior investigators in infectious diseases. [6] With the support of a CDC grant IDSA entertains a listserv for infectious disease physicians called Emerging Infections Network.